Cart
sales@molnova.com
Praluzatamab
CAS No. 2145109-70-0
Praluzatamab( —— )
Catalog No. M36824 CAS No. 2145109-70-0
Praluzatamab is a monoclonal antibody targeting an activated white blood cell adhesion molecule (ALCAM/CD116).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 534 | In Stock |
|
| 10MG | 825 | In Stock |
|
| 25MG | 1216 | In Stock |
|
| 50MG | 1609 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePraluzatamab
-
NoteResearch use only, not for human use.
-
Brief DescriptionPraluzatamab is a monoclonal antibody targeting an activated white blood cell adhesion molecule (ALCAM/CD116).
-
DescriptionPraluzatamab is a monoclonal antibody targeting the activated leukocyte cell adhesion molecule (ALCAM/CD116). Praluzatamab can be used to synthesize Praluzatamab ravtansine (antibody-drug conjugates). Praluzatamab can be used for research of cancers.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorADC Antibody
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2145109-70-0
-
Formula WeightApproximately 146.9 kDa.
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Martín-Sabroso C, et al. Antibody-Antineoplastic Conjugates in Gynecological Malignancies: Current Status and Future Perspectives. Pharmaceutics. 2021 Oct 15;13(10):1705. ?
molnova catalog
related products
-
Orexin A (human, rat...
Endogenous agonist at orexin receptors (Ki values are 20 and 38 nM for OX1 and OX2 receptors respectively). Stimulates feeding following central administration and may be involved in the control of sleep-wake cycle and other hypothalamic functions.
-
Diosniposide B
Diosniposide B
-
15α-Hydroxy-3,11,23-...
15-Hydroxy-3,11,23-trioxolanost-8,20-dien-26-oic acid (comound 35) is a triterpenoid that can be isolated from Ganoderma lucidum.
